Skip to content
Daily Bet Review UK

The Zimbabwean Government Rejects ‘One-Sided’ US Health Aid Deal Due to Information Fears

Medical funding image
The offered US funding was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has turned down a major American health deal worth $367m (£272m) spanning five years due to Washington's insistence on confidential data.

This rejection came to light after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesperson has since explained that the United States was demanding access to biological samples for research and commercial purposes while refused to guarantee the benefits from future medical innovations.

"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged continued talks to reach a agreement suitable to both sides so the country's vital HIV treatment initiative can be sustained.

Broader Context

Zimbabwe's decision comes after a similar case in Kenya, where a court blocked a similar health funding agreement following legal challenges were raised about the security of citizens' medical information.

Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had overseen aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government deals to boost openness and accountability.

According to reports, 16 African countries have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Deal

This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," the Ambassador commented.

However, official spokesman Nick Mangwana said the proposed deal was "unequal".

"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"In essence, our nation would provide the basic resources for medical research with no assurance that the end products would be available to our citizens should a new pandemic arise."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral deals were undermining frameworks already set up through the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.

"This mechanism is designed to guarantee that when a country provides its samples, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We encourage further discussions with our US partners on how future co-operation might be structured in a way that respects the independence and dignity of both nations."

Medical Community Reaction

Medical experts stated it understood the government's concerns, but urged that negotiations need to persist given that a large portion of the country's HIV programmes relied on external financing.

"In cases where specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it added.

This impasse emphasises the continuing challenges between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.

JH
By

Joseph Hernandez

Alex Thornton is a seasoned sports betting analyst with over a decade of experience in UK and European markets.

Daily Bet Review UK

Type to search articles.